Osimertinib + WBI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Osimertinib + WBI, covering 2021-04-02 to 2021-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI [Phase 2]